Beta Bionics Inc.(BBNX:US)
Market Cap$728.58M
Key Metrics
Price$16.35
Revenue (TTM)$110.24M
Holders Revenue (TTM)-
Gross Profit (TTM)$63M
Earnings (TTM)-$66.44M
EBITDA (TTM)-$69.88M
Op. Margin (TTM)-70.13%
Dividend Yield-
Holders Yield-
Cash on hand$30.21M
Total Assets$304.42M
Net Assets$271.25M
Total Debt$6.91M
Key Metrics
Price$16.35
Revenue (TTM)$110.24M
Holders Revenue (TTM)-
Gross Profit (TTM)$63M
Earnings (TTM)-$66.44M
EBITDA (TTM)-$69.88M
Op. Margin (TTM)-70.13%
Dividend Yield-
Holders Yield-
Cash on hand$30.21M
Total Assets$304.42M
Net Assets$271.25M
Total Debt$6.91M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $27.63M | $32.12M | $27.25M | $23.24M | $17.64M | $20.44M | $16.71M | $12.93M | $8.35M |
Cost of Revenue | $11.19M | $13.18M | $12.13M | $10.74M | $8.67M | $8.75M | $7.79M | $5.73M | $3.29M |
Gross Profit | $16.44M | $18.94M | $15.12M | $12.5M | $8.97M | $11.69M | $8.91M | $7.2M | $5.06M |
| $40.71M | $35.07M | $32.16M | $32.38M | $27.61M | $24.73M | $19.89M | $16.65M | $13.43M | |
| Research and Development | $10.36M | $10.13M | $8.2M | $8.87M | $7.59M | $9.21M | $5.14M | $5.48M | $4.46M |
| Selling, General, and Administrative | $30.35M | $24.94M | $23.97M | $23.5M | $20.02M | $15.51M | $14.75M | $11.18M | $8.97M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - |
Operating Income | -$24.27M | -$16.12M | -$17.04M | -$19.87M | -$18.64M | -$13.04M | -$10.98M | -$9.45M | -$8.37M |
| $2.38M | $2.66M | $2.83M | $3M | -$10.01M | -$5.07M | $1.24M | -$3M | -$10.48M | |
| Non-Operating Interest Income | $2.38M | $2.66M | $2.83M | $3.01M | $2.44M | $951K | $826K | $1.14M | $1.25M |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | $55K |
| Other Income/Expense | - | -$1K | - | -$2K | -$12.45M | -$6.02M | $417K | -$4.14M | -$11.68M |
Income Before Tax | -$21.9M | -$13.47M | -$14.21M | -$16.87M | -$28.66M | -$18.11M | -$9.74M | -$12.45M | -$18.85M |
Income Tax | - | - | - | - | - | - | - | - | - |
Net Income | -$21.9M | -$13.47M | -$14.21M | -$16.87M | -$28.66M | -$18.11M | -$9.74M | -$12.45M | -$18.85M |
Minority Interests | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$21.9M | -$13.47M | -$14.21M | -$16.87M | -$28.66M | -$18.11M | -$9.74M | -$12.45M | -$18.85M |
Shares Outstanding (Basic) | 44.44M | 44.19M | 43.63M | 43.39M | 30.71M | 42.86M | 42.86M | 30.5M | - |
Shares Outstanding (Diluted) | 44.44M | 44.19M | 43.63M | 43.39M | 30.71M | 42.86M | 42.86M | 30.5M | - |
EPS (Basic) | -$0.49 | -$0.30 | -$0.33 | -$0.39 | -$0.93 | -$0.42 | - | -$0.41 | - |
EPS (Diluted) | -$0.49 | -$0.30 | -$0.33 | -$0.39 | -$0.93 | -$0.42 | - | -$0.41 | - |
EBIT | -$24.27M | -$11.95M | -$17.04M | -$19.87M | -$18.64M | -$8.61M | -$15.41M | -$9.45M | -$18.79M |
EBITDA | -$23.28M | -$11.01M | -$16.36M | -$19.22M | -$5.59M | -$2.05M | -$15.21M | -$4.75M | -$6.57M |